Association of Biotechnology Led Enterprises

News

Ligand signs worldwide OmniAb platform license agreement with Sanofi

OmniAb is a three-species transgenic-animal platform consisting of five different technologies used for producing mono- and bispecific human therapeutic antibodies.

Dec 03, 2019

By : Team ABLE

On Worlds AIDS Day, NACO signs MoU with 18 key Ministries/Departments to augment AIDS treatment response

The event also saw launch of the NACO Mobile Application, new IEC Material for TI NGOs, Calendar-2020, and Comprehensive Module for Private Practitioners on Management of HIV/AIDS.

Dec 02, 2019

By : Team ABLE

DBT announces call for LOIs in the area of Problems associated with Women’s Health

The Department of Biotechnology is desirous of inviting fresh perspectives and ingenious ideas to identify the problems and possible interventions and solutions on issues concerning Women’s Health.

Dec 02, 2019

By : Team ABLE

Jubilant Biosys commences major capacity expansions for its Drug Discovery Services Business

In addition, the company has formed a new digital business unit comprising of Bio-Informatics, Data-curation for AI/ML, TrialStat EDC software as well as discovery focussed AI/ML capabilities.

Dec 02, 2019

By : Team ABLE

Novartis to acquire The Medicines Company for $9.7 bn

The Medicines Company’s inclisiran is a transformational medicine that reimagines the treatment of atherosclerotic heart disease and familial hypercholesterolemia.

Nov 25, 2019

By : Team ABLE